LEADER 02225nam  2200445   450 
001 9910317675203321
005 20230908204135.0
010   $a953-51-7347-2
010   $a953-51-2994-5
035   $a(CKB)4970000000099332
035   $a(NjHacI)994970000000099332
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/40370
035   $a(EXLCZ)994970000000099332
100   $a20221006d2017      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvances in treatment of hepatitis C and B /$fedited by Naglaa Allam
210   $cIntechOpen$d2017
210  1$aRijeka, Croatia :$cIntechOpen,$d[2017]
210  4$dİ2017
215   $a1 online resource (406 pages)
311   $a953-51-2993-7 
330   $aAs in many areas of medicine, treatment of viral hepatitis has seen an acceleration of change driven by new therapies and evolving technology. Thanks to the direct-acting antiviral agents (DAAs), the era of HCV eradication and cure has begun. As regards to hepatitis B therapy, potent antiviral drugs for suppression of viral replication are available, new research activities to enhance eradication are visible, and these may influence clinical practice in the coming years. This book covers the latest advances in hepatitis C and hepatitis B therapeutics as well as the emerging and investigational treatment strategies. ""Advances in Treatment of Hepatitis C and Hepatitis B"" book is an up-to-date source of information for physicians, residents, and advanced medical students seeking a broader understanding of treatment of viral hepatitis. The authors of the chapters come from many eminent centers around the world and are experts in their respective fields.
606   $aHepatitis C
610   $aMedicine
610   $aInternal Medicine
610   $aInfectious Diseases
610   $aHealth Sciences
615  0$aHepatitis C.
676   $a616.3623
702   $aAllam$b Naglaa
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910317675203321
996   $aAdvances in Treatment of Hepatitis C and B$92216568
997   $aUNINA